Citations

Mayo Clinic

Clear

4844 citation(s) found for "Yu, Eric".

Graphical Interpretation of the Solution to the Redundant Problem in Biomechanics
Chao, Eric, An, K.N.

Journal of Biomechanical Engineering | November 3, 2010 | Volume: 100 | Issue: 3 | Pages: 159-167

10.1115/1.3426207 Get It

Force analysis of musculoskeletal joint systems is a redundant problem since the number of unknowns exceeds the number of equilibrium and constraint equations. Such a problem has been analyzed previously by the method of permutation/combination and by optimization technique. This paper combines both methods and discusses the results in the light of a graphical presentation from which unique and nonunique solutions to the problem are elaborated. When the applied load is nominal, multiple solutions are possible to meet the functional requirements. However, under maximum strength, unique solution exists because the redundant muscles reach their physiological limits.
Association of a Fasting Glucose Genetic Risk Score With Subclinical Atherosclerosis
Rasmussen‐Torvik, Laura J. , Li, Man , Kao, Wen H., Couper, David , Boerwinkle, Eric , Bielinski, Suzette J. , Folsom, Aaron R. , Pankow, James S. , Ballantyne, Christie M. , Bielinski, Suzette , Ballantyne, Christie M , Pankow, James S , Couper, David , Rasmussen-Torvik, Laura J

Diabetes | October 30, 2010 | Volume: 60 | Issue: 1 | Pages: 331-335

10.2337/db10-0839 | PMID 21036910 Get It

OBJECTIVE Elevated fasting glucose level is associated with increased carotid intima-media thickness (IMT), a measure of subclinical atherosclerosis. It is unclear if this association is causal. Using the principle of Mendelian randomization, we sought to explore the causal association between circulating glucose and IMT by examining the association of a genetic risk score with IMT. RESEARCH DESIGN AND METHODS The sample was drawn from the Atherosclerosis Risk in Communities (ARIC) study and included 7,260 nondiabetic Caucasian individuals with IMT measurements and relevant genotyping. Components of the fasting glucose genetic risk score (FGGRS) were selected from a fasting glucose genome-wide association study in ARIC. The score was created by combining five single nucleotide polymorphisms (SNPs) (rs780094 [GCKR], rs560887 [G6PC2], rs4607517 [GCK], rs13266634 [SLC30A8], and rs10830963 [MTNR1B]) and weighting each SNP by its strength of association with fasting glucose. IMT was measured through bilateral carotid ultrasound. Mean IMT was regressed on the FGGRS and on the component SNPs, individually. RESULTS The FGGRS was significantly associated (P = 0.009) with mean IMT. The difference in IMT predicted by a 1 SD increment in the FGGRS (0.0048 mm) was not clinically relevant but was larger than would have been predicted based on observed associations between the FFGRS, fasting glucose, and IMT. Additional adjustment for baseline measured glucose in regression models attenuated the association by about one third. CONCLUSIONS The significant association of the FGGRS with IMT suggests a possible causal association of elevated fasting glucose with atherosclerosis, although it may be that these loci influence IMT through nonglucose pathways.
Summary of the Recommendations on Sexual Dysfunctions in Men
Montorsi, Francesco , Adaikan, Ganesan, Becher, Edgardo, Khoury, Saad, Lue, Tom F. , Sharlip, Ira D., Althof, Stanley E., Andersson, Karl-Eric, Brock, Gerald, Broderick, Gregory A. , Buvat, Jacques, Dean, John, Donatucci, Craig F., Eardley, Ian , Fugl-Meyer, Kerstin , Hackett, Geoff , Hatzichristou, Dimitris, Hellstrom, Wayne J.G. , Incrocci, Luca , Jackson, Graham, Levine, Laurence A. , Lewis, Ronald W., McCabe, Marita P. , McMahon, Chris G., Montague, Drogo K. , Montorsi, Piero, Mulhall, John P. , Pfaus, Jim, Porst, Hartmut, Ralph, David , Rosen, Raymond C., Sadeghi‐Nejad, Hossein , Shabsigh, Ridwan, Vardi, Yoram, Wallen, Kim , Wasserman, Marlene, Larcher, Alessandro , Giuliano, François , Burnett, Arthur L. “Bud” , Buvat, Jacques, Goldstein, Irwin , Kadıoğlu, Ateş , Maggi, Mario , Rowland, David L. , Stief, Christian G.

The Journal of Sexual Medicine | October 29, 2010 | Volume: 7 | Issue: 11 | Pages: 3572-3588

10.1111/j.1743-6109.2010.02062.x | PMID 21040491 Get It

ABSTRACT Introduction Sexual health is an integral part of overall health. Sexual dysfunction can have a major impact on quality of life and psychosocial and emotional well-being. Aim To provide evidence-based, expert-opinion consensus guidelines for clinical management of sexual dysfunction in men. Methods An international consultation collaborating with major urologic and sexual medicine societies convened in Paris, July 2009. More than 190 multidisciplinary experts from 33 countries were assembled into 25 consultation committees. Committee members established scope and objectives for each chapter. Following an exhaustive review of available data and publications, committees developed evidence-based guidelines in each area. Main Outcome Measures New algorithms and guidelines for assessment and treatment of sexual dysfunctions were developed based on work of previous consultations and evidence from scientific literature published from 2003 to 2009. The Oxford system of evidence-based review was systematically applied. Expert opinion was based on systematic grading of medical literature, and cultural and ethical considerations. Results Algorithms, recommendations, and guidelines for sexual dysfunction in men are presented. These guidelines were developed in an evidence-based, patient-centered, multidisciplinary manner. It was felt that all sexual dysfunctions should be evaluated and managed following a uniform strategy, thus the International Consultation of Sexual Medicine (ICSM-5) developed a stepwise diagnostic and treatment algorithm for sexual dysfunction. The main goal of ICSM-5 is to unmask the underlying etiology and/or indicate appropriate treatment options according to men’s and women’s individual needs (patient-centered medicine) using the best available data from population-based research (evidence-based medicine). Specific evaluation, treatment guidelines, and algorithms were developed for every sexual dysfunction in men, including erectile dysfunction; disorders of libido, orgasm, and ejaculation; Peyronie’s disease; and priapism. Conclusions Sexual dysfunction in men represents a group of common medical conditions that need to be managed from a multidisciplinary perspective.
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing
Feldman, Andrew L. , Smith, David I., Ansell, Stephen M. , Johnson, Sarah H. , Porcher, Julie C., Özsan, Nazan , Wieben, Eric D. , Eckloff, Bruce W., Vasmatzis, George , Doǧan, Ahmet , Smith, David I., Law, Mark E. , Feldman, Andrew L

Blood | October 29, 2010 | Volume: 117 | Issue: 3 | Pages: 915-919

10.1182/blood-2010-08-303305 | PMID 21030553 Get It

Abstract The genetics of peripheral T-cell lymphomas are poorly understood. The most well-characterized abnormalities are translocations involving ALK, occurring in approximately half of anaplastic large cell lymphomas (ALCLs). To gain insight into the genetics of ALCLs lacking ALK translocations, we combined mate-pair DNA library construction, massively parallel (“Next Generation”) sequencing, and a novel bioinformatic algorithm. We identified a balanced translocation disrupting the DUSP22 phosphatase gene on 6p25.3 and adjoining the FRA7H fragile site on 7q32.3 in a systemic ALK-negative ALCL. Using fluorescence in situ hybridization, we demonstrated that the t(6;7)(p25.3;q32.3) was recurrent in ALK-negative ALCLs. Furthermore, t(6;7)(p25.3;q32.3) was associated with down-regulation of DUSP22 and up-regulation of MIR29 microRNAs on 7q32.3. These findings represent the first recurrent translocation reported in ALK-negative ALCL and highlight the utility of massively parallel genomic sequencing to discover novel translocations in lymphoma and other cancers.
P4‐126: Cognitive Performance Correlates with Resting State Connectivity and is Effected by APOE Status
Younkin, Steve, Petersen, Ronald C. , Jones, David T. , Machulda, Mary M. , McDade, Eric , Vemuri, Prashanthi , Zeng, Guang‐Zhi , Knopman, David S. , Boeve, Bradley F. , Jack, Clifford R.

Alzheimer's & Dementia | October 26, 2010 | Volume: 6 | Issue: 4S_Part_21 | Pages: No page available

10.1016/j.jalz.2010.08.185 Get It

O4‐03‐07: A Comparison of Network Connectivity and Atrophy Patterns in Behavioral Variant Frontotemporal Dementia
Whitwell, Jennifer L. , Avula, Ramesh, Gunter, Jeffrey L. , Petersen, Ronald C. , Jones, David T. , Zeng, Guang‐Zhi , Vemuri, Prashanthi , McDade, Eric , Machulda, Mary M. , Knopman, David S. , Boeve, Bradley F. , Jack, Clifford R.

Alzheimer's & Dementia | October 26, 2010 | Volume: 6 | Issue: 4S_Part_20 | Pages: No page available

10.1016/j.jalz.2010.08.052 Get It

The STICH Trial: Evidence-Based Conclusions
Rouleau, Jean L. , Michler, Robert E. , Oh, Jae K. , O’Connor, Christopher M. , Desvigne‐Nickens, Patrice , Lee, Kerry L., Velazquez, Eric J. , Sopko, George S. , Jones, Robert H.

European Journal of Heart Failure | September 22, 2010 | Volume: 12 | Issue: 10 | Pages: 1028-1030

10.1093/eurjhf/hfq140 | PMID 20861132 Get It

Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort
Ardoin, S., Schanberg, LE, Sandborg, Christy , Yow, Eric, Barnhart, HX, Mieszkalski, K. L., Ilowite, NT, Scheven, Emily von , Eberhard, A., Levy, Deborah M. , Silverman, Earl D. , Bowyer, S., Punaro, Lynn, Singer, Nora G. , Sherry, DD, McCurdy, Deborah , Klein‐Gitelman, Marissa, Wallace, Carol A., Wagner‐Weiner, Linda , Higgins, GC, Brunner, HI, Jung, LK, Imundo, Lisa F., Soep, JB, Reed, AM, investigators, APPLE, Mellins, Elizabeth , Schanberg, LE, Kimura, Yuki , Bowyer, Suzanne L., Silver, Richard M. , investigators, APPLE

Lupus | September 22, 2010 | Volume: 19 | Issue: 11 | Pages: 1315-1325

10.1177/0961203310373937 | PMID 20861207 Get It

As part of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Trial, a prospective multicenter cohort of 221 children and adolescents with systemic lupus erythematosus (SLE) (mean age 15.7 years, 83% female) underwent baseline measurement of markers of cardiovascular risk, including fasting levels of high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides (TG), lipoprotein A (Lpa), homocysteine and high-sensitivity C-reactive protein (hs-CRP). A cross-sectional analysis of the baseline laboratory values and clinical characteristics of this cohort was performed. Univariable relationships between the cardiovascular markers of interest and clinical variables were assessed, followed by multivariable linear regression modeling. Mean levels of LDL, HDL, Lpa, TG, hs-CRP and homocysteine were in the normal or borderline ranges. In multivariable analysis, increased Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), prednisone dose, and hypertension (HTN) were independently associated with higher LDL levels. Higher hs-CRP and creatinine clearance were independently related to lower HDL levels. Higher body mass index (BMI), prednisone dose, and homocysteine levels were independently associated with higher TG levels. Only Hispanic or non-White status predicted higher Lpa levels. Proteinuria, higher TG and lower creatinine clearance were independently associated with higher homocysteine levels, while use of multivitamin with folate predicted lower homocysteine levels. Higher BMI, lower HDL, and longer SLE disease duration, but not SLEDAI, were independently associated with higher hs-CRP levels. The R 2 for these models ranged from 7% to 23%. SLE disease activity as measured by the SLEDAI was associated only with higher LDL levels and not with hs-CRP. Markers of renal injury (HTN, proteinuria, and creatinine clearance) were independently associated with levels of LDL, HDL, and homocysteine, highlighting the importance of renal status in the cardiovascular health of children and adolescents with SLE. Future longitudinal analysis of the APPLE cohort is needed to further examine these relationships.
The HIV-1 Central Polypurine Tract Functions as a Second Line of Defense against APOBEC3G/F
Hu, Chunling , Saenz, Dyana T. , Fadel, Hind J., Peretz, Mary, Poeschla, Eric M. , Walker, William H. , Hu, Chunling

Journal of Virology | September 15, 2010 | Volume: 84 | Issue: 22 | Pages: 11981-11993

10.1128/jvi.00723-10 | PMID 20844042 Get It

ABSTRACT HIV-1 and certain other retroviruses initiate plus-strand synthesis in the center of the genome as well as at the standard retroviral 3′ polypurine tract. This peculiarity of reverse transcription results in a central DNA “flap” structure that has been of controversial functional significance. We mutated both HIV-1 flap-generating elements, the central polypurine tract (cPPT) and the central termination sequence (CTS). To avoid an ambiguity of previous studies, we did so without affecting integrase coding. DNA flap formation was disrupted but single-cycle infection was unaffected in all target cells tested, regardless of cell cycle status. Spreading HIV-1 infection was also normal in most T cell lines, and flap mutant viruses replicated equivalently to the wild type in nondividing cells, including macrophages. However, spreading infection of flap mutant HIV-1 was impaired in non- vif -permissive cells (HuT78, H9, and primary human peripheral blood mononuclear cells [PBMCs]), suggesting APOBEC3G (A3G) restriction. Single-cycle infections confirmed that vif -intact flap mutant HIV-1 is restricted by producer cell A3G/F. Combining the Δ vif and cPPT-CTS mutations increased A3G restriction synergistically. Moreover, RNA interference knockdown of A3G in HuT78 cells released the block to flap mutant HIV-1 replication. Flap mutant HIV-1 also accrued markedly increased A3G-mediated G→A hypermutation compared to that of wild-type HIV-1 (a full log 10 in the 0.36 kb downstream of the mutant cPPT). We suggest that the triple-stranded DNA structure, the flap, is not the consequential outcome. The salient functional feature is central plus-strand initiation, which functions as a second line of defense against single-stranded DNA editing by A3 proteins that survive producer cell degradation by Vif.
Neuromuscular Paraneoplastic Syndromes: The Lambert-Eaton Myasthenic Syndrome
Prommer, Eric

Journal of Palliative Medicine | September 13, 2010 | Volume: 13 | Issue: 9 | Pages: 1159-1162

10.1089/jpm.2009.0418 | PMID 20836646 Get It